Achilles Therapeutics plc (ACHL)

NASDAQ: ACHL · IEX Real-Time Price · USD

0.889

+0.019 (2.18%)

Dec 29, 2023, 4:30 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Selling, General & Admin	21.12	21.97	11.1	4.7
Research & Development	57.26	42.22	22.63	9.07
Operating Expenses	78.38	64.2	33.73	13.78
Operating Income	-78.38	-64.2	-33.73	-13.78
Other Expense / Income	-7.32	-3.13	-0.53	0.22
Pretax Income	-71.07	-61.06	-33.2	-13.99
Income Tax	0.11	0.04	0	0
Net Income	-71.18	-61.1	-33.2	-13.99
Shares Outstanding (Basic)	39	29	1	1
Shares Outstanding (Diluted)	39	29	1	1
Shares Change	36.59%	2587.54%	66.03%	-
EPS (Basic)	-1.82	-2.13	-31.14	-21.79
EPS (Diluted)	-1.82	-2.13	-31.14	-21.79
Free Cash Flow	-67.05	-66.92	-37.1	-15.08
Free Cash Flow Per Share	-1.71	-2.33	-34.80	-23.49
EBITDA	-67.38	-57.77	-32.42	-13.69
Depreciation & Amortization	3.69	3.29	0.77	0.3
EBIT	-71.07	-61.06	-33.2	-13.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).